Brief: Aap Implantate gets about EUR 36.6 mln from sale of biomaterials business
11/05/2016 16:10
May 11 (Reuters) - Aap Implantate AG AAQG.DE :
* Receives proceeds of about 36.6 million euros ($41.83 million) from sale of biomaterials
business
* Completion of transaction will result in a positive one-time overall effect on earnings
level of 19 million - 20 million euros
* Company will use part of proceeds to finance further growth and to distribute part of them
to its shareholders
Source text for Eikon: ID:nHUG576km2
Further company coverage: AAQG.DE
($1 = 0.8749 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on aap Implantate AG
See all newsBrief: Aap Confirms Rubino Di Girolamo As CEO Through The End Of 2028 COO Agnieszka Mierzejewska Will Leave The Company At The End Of The Year
Brief: aap Implantate Says Postponement Of Publication Of Annual Financial Statements
Brief: Aap Implantate AG Says Increases Its EBITDA In 9M From - 1.6 Mln Euros To 0 Euros
Brief: aap Implantate Says Resumes Step-By-Step Restart Of It Systems
Brief: Aap Implantate Says Possible Cyber Attack On Co